1336657562087919617

At our Pipeline Deep Dive today, we’re presenting updates on the Phase 3 study of omidubicel, our commercial readiness and pipeline. These results move us a step closer to bringing a potentially curative cell therapy option patients. #InspiredToCure Read: https://t.co/5FP3p3NzZR https://t.co/9aRm7rObbK

Send us a message